About Cybin
Cybin is a biotech company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions.
Founded in 2019 by Eric So, John Kanakis and Paul Glavine.
- Founded
- 2019
- Employees
- 11 to 50
- Total funding
- $347.5M
- Headquarters
- Toronto
Leadership
The top of Cybin's org chart, with how many people report into each leader.
Aaron Bartlone
Chief Operating Officer
16 reports
Greg Cavers
Chief Financial Officer
6 reports
Gabe F.
Chief Legal Officer
5 reports
Robert Mino
General Counsel and IP Counsel - Cybin, Inc.
2 reports
Kenneth Avery
SVP, Chemistry & Manufacturing
2 reports
Geoff Varty
Head, R&D
1 report
Ellen James
Senior Director, Clinical Development
1 report
Alex Nivorozhkin
Chief Scientific Officer
Angela Sorie
Sr Director, Clinical Programs
Ryan Richardson
Director, Information Technology
Alex Kelly
Director Clinical Operations
Kristen Irizarry
Executive Assistant To Chief Executive Officer
Stephen Gorny
Director Clinical Operations
Kathy Dorsey
Senior Director Clinical Operations
9 reports
Victoria Attwooll
Associate Director Of Clinical Operations
2 reports
Liz Galic
Director, Operations
1 report
Meghan Good
Associate Director
Erica Olson
VP, Corporate Controller
1 report
Sarah Hamilton
Director Financial Operations & Strategic Operations, Cybin Inc
Rachel Y.
Investor Relations Analyst
Erica Olson Cpa, Ca
Vp, Corporate Controller
Board
Theresa Firestone
Lead Independent Director, Member of Audit, Governance and Nominating and Compensation Committees
Eric Hoskins
Independent Director
Grant Froese
Independent Director
Lynn Marie Morski
Clinical Advisor
Maurizio Fava
Clinical Advisor
Sherri M. Altshuler
Regulatory Advisor
Jobs at Cybin
No open positions right now. Explore more companies on TheJobsMap.